National authorities urged to address knowledge gaps and generate evidence about the dynamics of mpox transmission.

The company will ramp up manufacturing of its Jynneos vaccine to meet demand in worst-affected African countries and stockpiling richer nations.

The commercial implications of the miss are hard to call, but separate trials could offer hope.

With only one inflammatory bowel disease product, Lilly is betting big on Morphic and its Phase II oral integrin MORF-057, which would directly compete with Takeda blockbuster Entyvio.